Delivery Order SPE2DB25D7068-SPE2DB25FTVND
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,274.57 to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price, non-set-aside delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, reflecting the contractor's role in supplying critical pharmaceutical and vaccine...
- The Defense Logistics Agency awarded a delivery order valued at $2,488.11 to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine, and this procurement supports the federal government's medical supply requirements for...
- The Defense Logistics Agency awarded a delivery order valued at $52,280.31 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine, and this procurement supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $17,170.40 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 mL syringes on May 2, 2025, with an ultimate completion date of May 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine used to immunize infants against diphtheria,...
- The Defense Logistics Agency awarded a delivery order valued at $5,740.32 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pediarix is a pediatric combination vaccine used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a $7,793.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes, with an ultimate completion date of August 12, 2025. This is a non-set-aside award issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-transaction procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes valued at $1,733.55 with a firm fixed price structure. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $7,719.50 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine used to provide immunization against multiple diseases,...
- The Defense Logistics Agency awarded a delivery order valued at $9,898.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Pediarix is a combination pediatric vaccine used for immunization against multiple diseases, supporting...
- The Defense Logistics Agency awarded a delivery order valued at $7,598.83 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded contract utilizes firm fixed pricing and requires performance at the contractor's Conshohocken, Pennsylvania facility. Pediarix is a combination vaccine indicated for immunization against diphtheria, tetanus, pertussis, hepatitis B, polio, and haemophilus influenzae...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTVNDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,332.30 to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on February 24, 2025, with an ultimate completion date of February 25, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine used to provide immunization against multiple diseases, making this delivery critical for military healthcare and federal immunization programs. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a prime vendor supplying vaccines, medications, and medical supplies across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities worldwide. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements for essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 2/24/25 |